Liraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue.

Li X, Liu Y, Wang F, Zhang F, Zhang L, Dang Y, Qi X.

Open source

DOI
10.1007/s10557-026-07958-4
Published
2026-09-08
Container
Cardiovasc Drugs Ther
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10557-026-07958-4,
  title = {Liraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue.},
  author = {Li X and  Liu Y and  Wang F and  Zhang F and  Zhang L and  Dang Y and  Qi X.},
  year = {2026},
  journal = {Cardiovasc Drugs Ther},
  doi = {10.1007/s10557-026-07958-4},
  url = {https://doi.org/10.1007/s10557-026-07958-4}
}

RIS

TY  - JOUR
TI  - Liraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue.
AU  - Li X
AU  -  Liu Y
AU  -  Wang F
AU  -  Zhang F
AU  -  Zhang L
AU  -  Dang Y
AU  -  Qi X.
PY  - 2026
JO  - Cardiovasc Drugs Ther
DO  - 10.1007/s10557-026-07958-4
UR  - https://doi.org/10.1007/s10557-026-07958-4
ER  - 

APA

X, L., Y, L., F, W., F, Z., L, Z., Y, D., & X., Q. (2026). Liraglutide Ameliorates Atrial Fibrillation in Association with Enhanced Adiponectin Signaling in Epicardial Adipose Tissue.. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-026-07958-4

Source records